The U.S. Food and Drug Administration has approved Lynkuet, a new medication that does not contain hormones to treat hot ...

An international research team led by the Medical University of Vienna has demonstrated for the first time that thyroid ...

Big news in the menopause world: The Food and Drug Administration has just approved the drug elinzanetant as a non-hormonal ...

Progesterone Receptor Positive (PR+) breast cancer is a distinct biological subtype of hormone receptor positive breast cancer. This type of cancer grows in response to progesterone, a hormone that is ...

Lynkuet, a softgel pill taken at bedtime, is hormone-free, with its active ingredient, elinzanetant, working on receptors in ...

Clearance of Lynkuet provides a new alternative to hormone-based treatment for hot flashes and sets up a market battle with ...

The obesity epidemic challenges public health in the developed world, reducing the quality of life and threatening health even as it demands heavy investments in preventive and therapeutic medical ...

There’s more hope for the 85% of women women dealing with the uncomfortable and unpredictable sweating associated with ...

Higher follicle-stimulating hormone (FSH) levels were associated with lower hippocampal volumes in postmenopausal women, ...